MENU
+Compare
NVAX
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$6.57
Change
-$0.12 (-1.79%)
Capitalization
1.07B

NVAX Novavax Forecast, Technical & Fundamental Analysis

Novavax Inc is a biotechnology company that develops vaccines... Show more

Industry: #Biotechnology
NVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVAX with price predictions
Dec 11, 2025

NVAX's RSI Oscillator recovers from oversold territory

The RSI Indicator for NVAX moved out of oversold territory on November 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In of the 37 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for NVAX just turned positive on November 26, 2025. Looking at past instances where NVAX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVAX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVAX as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVAX entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (33.223) is normal, around the industry mean (28.362). P/E Ratio (3.269) is within average values for comparable stocks, (51.986). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.836). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (1.026) is also within normal values, averaging (336.196).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVAX is expected to report earnings to fall 60.73% to -49 cents per share on March 04

Novavax NVAX Stock Earnings Reports
Q4'25
Est.
$-0.49
Q3'25
Missed
by $0.71
Q2'25
Beat
by $0.68
Q1'25
Beat
by $3.36
Q4'24
Beat
by $0.09
The last earnings report on November 06 showed earnings per share of -125 cents, missing the estimate of -54 cents. With 2.93M shares outstanding, the current market capitalization sits at 1.07B.
A.I. Advisor
published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCLVX27.710.17
+0.62%
BlackRock Advantage Large Cap Val Inv C
PIOTX25.020.08
+0.32%
Victory Pioneer Core Equity A
PJEAX15.54N/A
N/A
PGIM US Real Estate A
FSEKX15.21N/A
N/A
Fidelity Advisor Sustainable U.S. Eq A
URNQX63.50-0.22
-0.35%
Victory Nasdaq 100 Index R6

NVAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with MRNA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
-0.74%
MRNA - NVAX
57%
Loosely correlated
+2.07%
BNTX - NVAX
44%
Loosely correlated
+0.28%
FHTX - NVAX
39%
Loosely correlated
+0.67%
XNCR - NVAX
39%
Loosely correlated
-0.58%
MNMD - NVAX
39%
Loosely correlated
+1.70%
More